三阴性乳腺癌中的 TIL(肿瘤浸润淋巴细胞)治疗:从机制探索到临床转化
Tumor-infiltrating lymphocyte therapy in triple-negative breast cancer: from mechanistic exploration to clinical translation.
乳腺癌是女性常见的恶性肿瘤,其中三阴性乳腺癌(TNBC)是一种预后较差的亚型。
63.4分
★★★☆☆
FRONTIER PAPERS
Tumor-infiltrating lymphocyte therapy in triple-negative breast cancer: from mechanistic exploration to clinical translation.
乳腺癌是女性常见的恶性肿瘤,其中三阴性乳腺癌(TNBC)是一种预后较差的亚型。
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.
TNBC仅占新发乳腺癌诊断的约15%-20%;
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。